Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Inflammatory protein produced by mast cells contributes to fibrosis in gastric cancer

Gastric cancer, one of the leading causes of cancer-associated mortality worldwide, is renowned for its ability to disseminate throughout the peritoneal cavity.

26 Aug 2020

Study reveals a promising method for treating multiple sclerosis

A research team led by neurobiologist Professor Claire Jacob has identified an important mechanism that can be used to control the restoration of myelin sheaths following traumatic injury and in degenerative diseases.

24 Aug 2020

Doctors with disabilities call for a paradigm shift to make medical education, profession more inclusive

Doctors treat and heal patients, but they are seldom seen as people who may themselves require care or accommodation. Medics with disabilities are now calling for a paradigm shift in this mindset to make medical education and the profession more inclusive.

21 Aug 2020

New book series advances the development of pharmaceutical agents for treating neurological, CNS disorders

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders.

21 Aug 2020

CZI announces $4.5 million to advance novel approaches in neurodegeneration field

Today, the Chan Zuckerberg Initiative announced $4.5 million in funding to support 30 pairs of researchers to collaborate and apply novel approaches for gaining greater insight into neurodegenerative disorders such as Alzheimer's, Parkinson's, and ALS.

19 Aug 2020

Cashew shell compound may help repair damaged nerves

In laboratory experiments, a chemical compound found in the shell of the cashew nut promotes the repair of myelin, a team from Vanderbilt University Medical Center reports today in the Proceedings of the National Academy of Sciences.

17 Aug 2020

Newly identified gene could improve treatment for multiple sclerosis

The disease multiple sclerosis (MS) attacks the central nervous system and, with time, can give rise to muscle tremors and loss of balance.

14 Aug 2020

Neil Bell appointed as Chief Development Officer of Avacta Life Sciences

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce the appointment of Neil Bell as Chief Development Officer of Avacta Life Sciences with immediate effect. Neil will be responsible for late stage pre-clinical and early clinical development of Avacta’s pipeline of pre|CISION pro-drugs and Affimer immunotherapies.

From Avacta Life Sciences Ltd. 13 Aug 2020

Reelin inhibition may be effective for treating multiple sclerosis

In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

12 Aug 2020

Study: Individuals who feel dizzy when they stand up may have an increased risk of dementia

Some people who feel dizzy or lightheaded when they stand up may have an increased risk of developing dementia years later, according to a new study published in Neurology®, the medical journal of the American Academy of Neurology.

7 Aug 2020

Climate change and disruption of ecosystem affect allergies, respiratory disorders

Climate change and disruption of the ecosystem have the potential to profoundly impact the human body. Xue Ming, professor of neurology at Rutgers New Jersey Medical School, who recently published a paper in the International Journal of Environmental Research and Public Health on the effects of climate change on allergies, autoimmunity and the microbiome - the beneficial microorganisms that live on and inside the human body - discusses how the delicate balance of the environment affects conditions such as allergies, autism, and immune disorders.

6 Aug 2020

Discovery of new mechanism in the immune system provides better understanding of diseases

An active immune system protects against diseases and infections. An overactive immune system is the body's worst enemy. One example of this is multiple sclerosis, which is a so-called autoimmune disease, while an overactive immune system also leads to some COVID-19 patients becoming seriously ill.

4 Aug 2020

Discovery could have important implications for brain infections, neurodegenerative diseases

More than 30 million Americans are infected with a brain parasite spread by cats and contaminated meat, but most will never show symptoms.

31 Jul 2020

Anti-inflammatory Tetracycline activity may modulate COVID-19 severity

The current COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), seems to attack the human airway epithelium primarily. In severely affected patients, the illness progresses to hypoxemic respiratory failure and acute respiratory distress syndrome (ARDS). The latter is treatable mainly by supportive management.

30 Jul 2020

Study reveals neural mechanisms underlying state mental fatigue in multiple sclerosis

Researchers at Kessler Foundation conducted a pilot study comparing the effects of mental fatigue on brain activation patterns in people with and without multiple sclerosis (MS).

28 Jul 2020

Human genome may explain the neonatal origins of chronic immune and inflammatory diseases

A study published in the journal Nature Communications has pinpointed a number of areas of the human genome that may help explain the neonatal origins of chronic immune and inflammatory diseases of later life, including type 1 diabetes, rheumatoid arthritis and coeliac disease.

28 Jul 2020

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Inflammatory protein produced by mast cells contributes to fibrosis in gastric cancer

Study reveals a promising method for treating multiple sclerosis

Doctors with disabilities call for a paradigm shift to make medical education, profession more inclusive

New book series advances the development of pharmaceutical agents for treating neurological, CNS disorders

CZI announces $4.5 million to advance novel approaches in neurodegeneration field

Cashew shell compound may help repair damaged nerves

Newly identified gene could improve treatment for multiple sclerosis

Neil Bell appointed as Chief Development Officer of Avacta Life Sciences

Reelin inhibition may be effective for treating multiple sclerosis

Study: Individuals who feel dizzy when they stand up may have an increased risk of dementia

Climate change and disruption of ecosystem affect allergies, respiratory disorders

Discovery of new mechanism in the immune system provides better understanding of diseases

Discovery could have important implications for brain infections, neurodegenerative diseases

Anti-inflammatory Tetracycline activity may modulate COVID-19 severity

Study reveals neural mechanisms underlying state mental fatigue in multiple sclerosis

Human genome may explain the neonatal origins of chronic immune and inflammatory diseases

Study uncovers dual role for molecule involved in autoimmune eye disease

White blood cells and their role in the brain

Study points to an important role for white blood cells in brain development

Using AI to pinpoint neurons involved in gait reacquisition

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in